Elite Pharmaceuticals Inc. (OTC:ELTP) Stock In Focus After Filing ANDA with US FDA to Market Central Nervous System Stimulant
Investors are often on the lookout for the latest potential plays in the pharmaceutical sector, and based on the developments
Read more